金融业


销售 更改 日
Acadia Pharmaceuticals USD 342M 34.04M 2026-09
Alnylam Pharmaceuticals USD 1.46B 170M 2026-09
Amarin USD 49.22M 451K 2025-12
BioCryst Pharmaceuticals USD 218.25M 188.3M 2026-06
BioMarin Pharmaceutical USD 1.03B 40M 2026-09
DBV Technologies USD 1.6M 955K 2026-09
Halozyme Therapeutics USD 492.97M 11.97M 2026-09
Incyte USD 1.56B 110M 2026-09
Insmed USD 524.42M 98.93M 2026-09
Ionis Pharmaceuticals USD 243M 25M 2026-09
Neurocrine Biosciences USD 1.12B 161M 2026-09
PTC Therapeutics USD 357.8M 3.2M 2026-09
Sarepta Therapeutics USD 381.4M 19.9M 2026-09
Ultragenyx Pharmaceutical USD 173M 41M 2026-09
United Therapeutics USD 832.5M 49.2M 2026-09